Advanced search
Publication Cover
Current Medical Research and Opinion Volume 27, 2011 - Issue sup2: CMRO Online Special Issue on Attention Deficit Hyperactivity Disorder
Submit an article Journal homepage
792
Views
35
CrossRef citations to date
0
Altmetric
Original Article

Treatment outcomes with methylphenidate formulations among patients with ADHD: retrospective claims analysis of a managed care population

Paul HodgkinsGlobal Health Economics and Outcomes Research, Shire Development Inc. Wayne, PAUSACorrespondence[email protected]
,
Rahul SasanéGlobal Health Economics and Outcomes Research, Shire Development Inc. Wayne, PAUSA
,
Laura ChristensenOptumInsight Ann Arbor, MIUSA
,
Carolyn HarleyOptumInsight Palo Alto, CAUSA
&
Fang LiuOptumInsight Eden Prairie, MNUSA
Pages 53-62 | Accepted 09 Sep 2011, Published online: 05 Oct 2011

Citations (35)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Jeff Schein, Ann Childress, Julie Adams, Martin Cloutier, Patrick Gagnon-Sanschagrin, Jessica Maitland, Rebecca Bungay, Annie Guérin & Patrick Lefebvre. (2021) Treatment patterns among adults with attention-deficit/hyperactivity disorder in the United States: a retrospective claims study. Current Medical Research and Opinion 37:11, pages 2007-2014.
Read now
Zhou Zhou, Zheng-Yi Zhou, Sneha S. Kelkar, Vanja Sikirica, Jipan Xie & Regina Grebla. (2018) Medication use in adults with attention deficit/hyperactivity disorder in a commercially-insured population in the United States. Current Medical Research and Opinion 34:4, pages 585-592.
Read now
Timothy Wigal, Ann Childress, Glen Frick, Brian Yan, Sharon Wigal & Manisha Madhoo. (2018) Effects of SHP465 mixed amphetamine salts in adults with ADHD in a simulated adult workplace environment. Postgraduate Medicine 130:1, pages 111-121.
Read now
Kavita Gajria, Mei Lu, Vanja Sikirica, Peter Greven, Yichen Zhong, Paige Qin & Jipan Xie. (2014) Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder – a systematic literature review. Neuropsychiatric Disease and Treatment 10, pages 1543-1569.
Read now
Alonso Montoya, Amaia Hervás, Joaquín Fuentes, Esther Cardo, Pepa Polavieja, Javier Quintero & Rosemary Tannock. (2014) Cluster-randomized, controlled 12-month trial to evaluate the effect of a parental psychoeducation program on medication persistence in children with attention-deficit/hyperactivity disorder. Neuropsychiatric Disease and Treatment 10, pages 1081-1092.
Read now
Regina Bussing, Komal J. Narwaney, Almut G. Winterstein, Douglas A. Newton, Lynn DeBar, Joseph A. Boscarino, Sengwee Toh, Pamala Pawloski, James D. Nordin, Lisa J. Herrinton, Dana Mason & Matthew F. Daley. (2014) Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics. Current Medical Research and Opinion 30:8, pages 1687-1699.
Read now
Rana Ahmed & Parisa Aslani. (2013) Attention-deficit/hyperactivity disorder: an update on medication adherence and persistence in children, adolescents and adults. Expert Review of Pharmacoeconomics & Outcomes Research 13:6, pages 791-815.
Read now

Articles from other publishers (28)

Lucy Barnard-Brak, Allie Marques & Carolina Kudesey. (2023) Medication Non-Adherence and Tolerance Breaks Among Adolescents and Young Adults With ADHD. Journal of Attention Disorders 27:9, pages 1020-1026.
Crossref
Jeff Schein, Ann Childress, Martin Cloutier, Urvi Desai, Andi Chin, Mark Simes, Annie Guerin & Julie Adams. (2022) Reasons for treatment changes in adults with attention-deficit/hyperactivity disorder: a chart review study. BMC Psychiatry 22:1.
Crossref
Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Rebecca Bungay, Annie Guerin & Ann Childress. (2022) Reasons for Treatment Changes in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Chart Review Study. Advances in Therapy 39:12, pages 5487-5503.
Crossref
Jeff Schein, Ann Childress, Julie Adams, Patrick Gagnon-Sanschagrin, Jessica Maitland, Wendi Qu, Martin Cloutier & Annie Guérin. (2022) Treatment patterns among children and adolescents with attention-deficit/hyperactivity disorder in the United States – a retrospective claims analysis. BMC Psychiatry 22:1.
Crossref
Rebecca Parkin, Fiona Mc Nicholas & John C. Hayden. (2022) A systematic review of interventions to enhance adherence and persistence with ADHD pharmacotherapy. Journal of Psychiatric Research 152, pages 201-218.
Crossref
Benjamin Selaskowski, Christian Staerk, Niclas Braun, Swantje Matthies, Erika Graf, Michael Colla, Christian Jacob, Esther Sobanski, Barbara Alm, Michael Roesler, Wolfgang Retz, Petra Retz-Junginger, Bernhard Kis, Mona Abdel-Hamid, Michael Huss, Thomas Jans, Ludger Tebartz van Elst, Mathias Berger, Silke Lux, Andreas Mayr & Alexandra Philipsen. (2022) Multimodal treatment efficacy differs in dependence of core symptom profiles in adult Attention-Deficit/Hyperactivity Disorder: An analysis of the randomized controlled COMPAS trial. Journal of Psychiatric Research 151, pages 225-234.
Crossref
Christopher Wohkittel, Oliver Scherf-ClavelStefanie Fekete, Marcel Romanos, Petra HöggerManfred Gerlach. (2022) Determination of Guanfacine in Oral Fluid and Serum of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Short Communication. Therapeutic Drug Monitoring 44:2, pages 340-344.
Crossref
Christopher Wohkittel, Petra HöggerStefanie Fekete, Marcel Romanos & Manfred Gerlach. (2021) Relationship Between Amphetamine Concentrations in Saliva and Serum in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder. Therapeutic Drug Monitoring 43:4, pages 564-569.
Crossref
Muhammad Umair Khan & Parisa Aslani. (2020) Exploring factors influencing initiation, implementation and discontinuation of medications in adults with ADHD. Health Expectations 24:S1, pages 82-94.
Crossref
Asami Ishizuya, Minori Enomoto, Hisateru Tachimori, Hidehiko Takahashi, Genichi Sugihara, Shingo Kitamura & Kazuo Mishima. (2021) Risk factors for low adherence to methylphenidate treatment in pediatric patients with attention-deficit/hyperactivity disorder. Scientific Reports 11:1.
Crossref
Laura Ghirardi, Qi Chen, Zheng Chang, Ralf Kuja‐Halkola, Charlotte Skoglund, Patrick D. Quinn, Brian M. D'Onofrio & Henrik Larsson. (2019) Use of medication for attention‐deficit/hyperactivity disorder and risk of unintentional injuries in children and adolescents with co‐occurring neurodevelopmental disorders. Journal of Child Psychology and Psychiatry 61:2, pages 140-147.
Crossref
Muhammad Umair KhanParisa Aslani. (2019) A Review of Factors Influencing the Three Phases of Medication Adherence in People with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology 29:6, pages 398-418.
Crossref
Joseph C. Blader. 2019. Psychiatric Nonadherence. Psychiatric Nonadherence 17 30 .
Alexander Häge, Lisa Weymann, Lucia Bliznak, Viktoria Märker, Konstantin Mechler & Ralf W. Dittmann. (2018) Non-adherence to Psychotropic Medication Among Adolescents – A Systematic Review of the Literature. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie 46:1, pages 69-78.
Crossref
Yan LiWei LiuYanmin ZhuXinyue LiuAlmut Gertrud Winterstein. (2017) Determinants of Pharmacological Treatment Initiation and Persistence in Publicly Insured Adults With Attention-Deficit/Hyperactivity Disorder. Journal of Clinical Psychopharmacology 37:5, pages 546-554.
Crossref
Maria Emilsson, Per A. Gustafsson, Gisela Öhnström & Ina Marteinsdottir. (2016) Beliefs regarding medication and side effects influence treatment adherence in adolescents with attention deficit hyperactivity disorder. European Child & Adolescent Psychiatry 26:5, pages 559-571.
Crossref
Juliana Meyers, Kavita Gajria, Sean D Candrilli, Moshe Fridman & Vanja Sikirica. (2017) The impact of adjunctive guanfacine extended release on stimulant adherence in children/adolescents with attention-deficit/hyperactivity disorder. Journal of Comparative Effectiveness Research 6:2, pages 109-125.
Crossref
Rana Ahmed, Jacqueline Borst, Yong C. Wei & Parisa Aslani. (2016) Parents’ Perspectives About Factors Influencing Adherence to Pharmacotherapy for ADHD. Journal of Attention Disorders 21:2, pages 91-99.
Crossref
Roger Mulder, Philip Hazell, Julia J Rucklidge & Gin S Malhi. (2016) Methylphenidate for attention-deficit/hyperactivity disorder: Too much of a good thing?. Australian & New Zealand Journal of Psychiatry 50:2, pages 113-114.
Crossref
Peter M. Wehmeier, Ralf W. Dittmann & Tobias Banaschewski. (2014) Treatment compliance or medication adherence in children and adolescents on ADHD medication in clinical practice: results from the COMPLY observational study. ADHD Attention Deficit and Hyperactivity Disorders 7:2, pages 165-174.
Crossref
Tanjala T. Gipson, Eboni I. Lance, Rebecca A. Albury, Maura B. Gentner & Mary L. Leppert. (2014) Disparities in Identification of Comorbid Diagnoses in Children With ADHD. Clinical Pediatrics 54:4, pages 376-381.
Crossref
Juliana Setyawan, Moshe Fridman, Paul Hodgkins, Javier Quintero, M. Haim Erder, Božena J. Katić & Valerie Harpin. (2014) Relationship between symptom impairment and treatment outcome in children and adolescents with attention-deficit/hyperactivity disorder: a physician perspective. ADHD Attention Deficit and Hyperactivity Disorders 7:1, pages 75-87.
Crossref
Wolfgang Retz & Petra Retz-Junginger. (2014) Prediction of methylphenidate treatment outcome in adults with attention-deficit/hyperactivity disorder (ADHD). European Archives of Psychiatry and Clinical Neuroscience 264:S1, pages 35-43.
Crossref
E. Sobanski, W. Retz, R. Fischer, C. Ose, B. Alm, O. Hennig & M. Rösler. (2020) Treatment adherence and persistence in adult ADHD: Results from a twenty-four week controlled clinical trial with extended release methylphenidate. European Psychiatry 29:5, pages 324-330.
Crossref
Juliana Setyawan, Moshe Fridman, Paul Hodgkins, Javier Quintero, M Haim Erder, Božena Katić & Valerie Harpin. (2013) Physician-reported treatment outcomes for ADHD among children and adolescents in Europe. Neuropsychiatry 3:6, pages 587-600.
Crossref
Farasat A. S. Bokhari & Gary M. Fournier. (2013) Entry in the ADHD drugs market: Welfare impact of generics and me‐too's . The Journal of Industrial Economics 61:2, pages 339-392.
Crossref
István Bitter, Anna Angyalosi & Pál Czobor. (2012) Pharmacological treatment of adult ADHD. Current Opinion in Psychiatry 25:6, pages 529-534.
Crossref
Farasat A. S. Bokhari & Gary M. Fournier. (2012) Entry in the ADHD Drugs Market: Welfare Impact of Generics and Me-Toos. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.